The continued increase in the prevalence of severe obesity (SO; 120% of the 95th body mass index [BMI] percentile) among youth, 1 particularly among adolescents, 2 is a major medical and public health challenge. 3 Understanding the impact of SO on risk factors for chronic disease, particularly cardiovascular disease (CVD), will be important to help guide screening and treatment efforts. The prevalence of many CVD risk factors (e.g., hypertension, dyslipidemia, and prediabetes) and the subclinical manifestation of CVD (e.g., vessel wall thickness and left ventricular mass) are higher among youth with SO than their peers with normal weight (NW), overweight (OW), or obesity (OB). 3, 4 The association of OB with peripherally measured blood pressure (BP) among youth has been well documented. [5] [6] [7] [8] [9] [10] Although hypertension is clinically diagnosed by brachial artery sphygmomanometry, 11,12 emerging data suggest that central aortic BP may be more strongly associated with vascular damage, atherosclerosis, and future CVD risk. [13] [14] [15] [16] [17] Central aortic BP within the ascending aorta can be directly measured using a pressure transducer introduced into the aortic root at the time of cardiac catheterization. 18 Recently, noninvasive techniques that derive central aortic pressures via applanation tonometry have been developed. However, limited data of central aortic BP exist among pediatric populations particularly in the context of SO, as this research has been predominately conducted among older adults. 19, 20 Moreover, though sex differences have been established in adults, 21 no data are present among youth using applanation tonometry.
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Therefore, the purpose of this study was to characterize the role of SO and sex in relation to central aortic BP among children and adolescents. We hypothesized that youth with SO would exhibit higher central aortic BP compared with moderate OB, OW, and NW and that males would have higher central aortic BP compared with females. adolescents throughout a range of BMI values. Participants were recruited from the University of Minnesota Masonic Children's Hospital Pediatric Weight Management Clinic, general pediatric clinics, and the community within the Minneapolis−St. Paul metropolitan area. Exclusion criteria included OB due to a genetic cause, bariatric surgery, current use of antihypertensive medications, type 1 diabetes mellitus, history of hypercholesterolemia, chronic kidney disease, Kawasaki disease, autoimmune inflammatory diseases, and congenital heart disease. This study was approved by the institutional review board at the University of Minnesota. All procedures were followed in accordance with the institutional review board and Health Insurance Portability and Accountability Act (HIPAA) guidelines.
METHODS

Data
Parents and participants provided informed consent and assent, respectively.
Anthropometric measurements
All testing was performed at the University of Minnesota, with the participants fasted for at least 12 hours before their study visit. Height and body mass were measured 3 times on the same day using a wall-mounted stadiometer and an electric scale (ST Scale-Tronix, White Plains, NY), and the average was recorded. BMI was calculated using body mass in kilograms (kg) divided by height in squared meters (m 2 ). OB status was determined by BMI percentiles and stratified into 3 categories: NW (i.e., ≥5th to <85th BMI percentile), OW/OB (i.e., ≥85th to <95th BMI Obesity status is presented as normal weight (e.g., ≥5th to <85th BMI percentile), overweight/obesity (e.g., ≥85th to <95th BMI percentile, ≥100% to <120% of the 95th BMI percentile), and severe obesity (e.g., ≥120% of the 95th BMI percentile). Continuous variables are presented as mean ± SE. Race, Tanner stage, and hypertension status are presented as count (% within column). Analysis of variance and chi-squared test assessed sex differences in continuous and categorical variables, respectively. Abbreviation: BMI, body mass index.
a Significantly different compared with normal weight as determined by Bonferroni post hoc comparisons (P < 0.05). b Significantly different compared with overweight/obesity as determined by Bonferroni post hoc comparisons (P < 0.05).
percentiles, ≥100% to <120% of the 95th BMI percentiles), and SO (i.e., ≥120% of the 95th BMI percentile or absolute BMI > 35 kg/m 2 ). Body composition was measured using dual-energy X-ray absorptiometry (iDXA; General Electronic Medical Systems, Madison WI) and data were analyzed using Encore software version 16.0. Trained medical providers determined pubertal maturation using Tanner stages (I−V).
Brachial BP and heart rate
Seated brachial systolic blood pressure (SBP) and diastolic blood pressure (DBP) were obtained on the right arm after participants rested for 10 minutes with legs uncrossed via an automated sphygmomanometer (Colin BP-8800; Colin Medical Instruments, San Antonio TX). BP was measured in triplicate with 3-minute intervals between each measure. The average of the last 2 measures was recorded. Brachial BP percentile was calculated based on age, sex, and height. Hypertension status was determined by using the current recommendations from the American Academy of Pediatrics and stratified into the following categories: normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension. 22 
Measurement of aortic BP and arterial stiffness
Following 15 minutes of supine rest, radial and carotid arterial waveforms were recorded via applanation tonometry using SphygmoCor MM3 software (AtCor Medical, Sydney Australia). The tonometer was positioned over the strongest pulse point on the artery, and a minimum of 11 seconds of consistent arterial waveforms were recorded after a strong and reproducible pulse was obtained. Collected waveforms were calibrated and scaled using each participant's resting brachial BP, and a validated generalized transfer function estimated the corresponding central aortic BP.
Statistical analysis
SPSS Statistics 23, released 2016 (IBM, IBM SPSS Statistics for Windows, Armonk, NY) was used for statistical analysis. A 1-way analysis of variance (ANOVA) and a chi-square test assessed sex differences in clinical and demographic characteristics (e.g., race and Tanner stage), respectively. Sex-and OB-related differences regarding central aortic BP were evaluated by a 1-way ANOVA, and an analysis of covariance adjusted for Tanner stage, age, race, sex, height, and BMI percentile. A 2-way multivariate ANOVA, with adjustment for Tanner stage, age, race, and height, tested for an interaction between OB status and sex. Multiple linear regression evaluated the association of Tanner stage, sex, race, BMI percentile, percent fat mass, and visceral adipose tissue with measures of central aortic BP. Adjusted Pearson correlation coefficients measured the strength of the association between anthropometric and body composition measures with central aortic BP.
RESULTS
Cohort demographics and clinical characteristics are presented in Table 1 . Compared with males, females were significantly shorter (P = 0.02) and had a higher BMI (P = 0.02), BMI percentile (P = 0.05), hip circumference (P = 0.04), fat mass (P = 0.02), and percent fat mass (P < 0.001). There were no significant sex differences regarding race (P = 0.21), Tanner stage (P = 0.06), and hypertension status (P = 0.30). Subjects with SO were significantly older compared to subjects with NW (P = 0.01) and OW/OB (P = 0.05). Compared to subjects with NW, subjects with SO had higher hip circumference (P < 0.001), waist circumferences (P < 0.001), lean muscle mass (P < 0.001), fat mass (P < 0.001), percent fat mass (P < 0.001), and visceral adipose tissue (P < 0.001). Subjects with SO also had significantly greater hip circumference (P < 0.001), waist circumference (P < 0.001), lean muscle mass (P < 0.001), fat mass (P < 0.001), percent fat mass (P < 0.001), and visceral adipose tissue (P < 0.001) compared to subjects with OW/OB. Race did not differ by OB status (P = 0.08). Higher Tanner stages were associated with increased OB status (P = 0.002), and the proportion of subjects with hypertension was greater among subjects with SO (P < 0.001). Table 2 presents sex differences with both peripheral and central aortic BP. Unadjusted radial−aortic SBP (P = 0.04) and radial−aortic DBP (P = 0.03) were significantly higher among females. After adjusting for covariates, radial−aortic SBP (P = 0.39) and radial−aortic DBP (P = 0.44) were both not significantly different between males and females. No differences between sexes were found for brachial SBP (P = 0.43), brachial DBP (P = 0.33), carotid−aortic SBP (P = 0.99), and carotid−aortic DBP (P = 0.53). Table 3 displays peripheral and central aortic BP stratified by OB status. Compared to NW, SO participants had higher unadjusted radial−aortic SBP (P < 0.001), radial−aortic DBP (P < 0.001), carotid−aortic SBP (P < 0.001), and carotid−aortic DBP (P = 0.004). After adjusting for covariates, radial− aortic SBP (P < 0.001), carotid−aortic SBP (P < 0.001), and carotid−aortic DBP (P = 0.04) remained higher among SO participants. Compared to OW/OB, SO participants had higher unadjusted radial−aortic SBP (P = 0.04), radial− aortic DBP (P = 0.03), and carotid−aortic SBP (P = 0.001). Following adjustment, participants with SO consistently had higher radial−aortic SBP (P = 0.002) and carotid−aortic SBP (P = 0.007) compared to participants with OW/OB. Results from a 2-way multivariate ANOVA depicted a nonsignificant interaction between OB status and sex regarding radial−aortic SBP (P = 0.99), radial−aortic DBP (P = 0.69), carotid− aortic SBP (P = 0.74), and carotid−aortic DBP (P = 0.67).
Regression analysis on radial−aortic BP is presented in Table 4 . After adjusting for Tanner stage, sex, race, and percent fat mass, BMI was significantly associated with both radial−aortic SBP (β = 0.9, P < 0.001) and DBP (β = 0.5, P < 0.001). Supplementary Data present regression analysis on carotid−aortic SBP and DBP, in which BMI was similarly significantly associated with carotid−aortic SBP (β = 0.8, P < 0.001) and DBP (β = 0.4, P < 0.001). Percent fat mass was not associated with radial−aortic SBP (β = −0.1, P = 0.38) and DBP (β = −0.1, P = 0.21) (Table 4) , carotid− aortic SBP (β = −0.07, P = 0.68), or DBP (β = −0.1, P = 0.64) (Supplementary Table 1 ). Visceral adipose tissue was only significantly associated with carotid−aortic SBP (β = 0.006, P = 0.05). With the inclusion of both age and Tanner stage Reported as mean with 95% confidence interval. Obesity status is presented in three categories: normal weight (e.g., ≥5th to <85th BMI percentile), overweight/obesity (e.g., ≥85th to <95th BMI percentile, ≥100% to <120% of the 95th BMI percentile), and severe obesity (e.g., ≥120% of the 95th BMI percentile). Abbreviation: BMI, body mass index.
a Adjustment for Tanner stage, sex, race, age, and height by an analysis of covariance. b Significantly different compared with normal weight as determined by Bonferonni post hoc pairwise comparisons (P < 0.05). c Significantly different compared with overweight/obesity as determined by Bonferonni post hoc pairwise comparisons (P < 0.05).
in the regression analysis, BMI continued to be significantly associated with both radial−aortic SBP (β = 0.7, P < 0.001) and DBP (β = 0.3, P < 0.001) (Supplementary Table 2 ); similar results were observed for carotid−aortic SBP (β = 0.7, P < 0.001) and DBP (β = 0.2, P = 0.001) (Supplementary Table 3 ). After adjusting for Tanner stage, race, and sex, strong associations were observed between radial−aortic SBP with waist circumference (r = 0.56 P < 0.001), body mass (r = 0.60, P < 0.001), BMI (r = 0.56, P < 0.001), and visceral adipose tissue (r = 0.51, P < 0.001). In addition, carotid−aortic SBP was strongly associated with waist circumference (r = 0.52, P < 0.001), body mass (r = 0.56, P < 0.001), and visceral adipose tissue (r = 0.51, P < 0.001). Moderate associations were observed between body mass and both radial−aortic DBP (r = 0.42, P < 0.001) and carotid−aortic DBP (r = 0.43, P < 0.001).
DISCUSSION
In this study, we observed higher levels of central aortic BP in youth with SO compared to those with OW/OB and NW. However, levels of central aortic BP did not differ between females and males. In comparison to percent fat mass and visceral adipose tissue, BMI was more strongly associated with central aortic SBP and DBP. These data suggest that youth with SO may be at increased risk of developing hypertension and CVD later in adulthood, which could be in part mediated by higher central aortic BP. Moreover, though brachial BP is a valid predictor of future CVD risk and is clinically used in the diagnosis of hypertension, our data suggest that central aortic BP may also be a relevant risk factor for CVD. 18, 23 This is in line with data from adults showing that compared to peripheral BP, stronger associations between central aortic BP have been observed with adverse CVD risk factors including left ventricular hypertrophy, 24 carotid intima-media thickness, 16 and atherosclerosis. 13 Pichler et al. 25 reported significantly higher peripheral and central aortic BPs among adults with OB. We similarly observed that excess adiposity was associated with higher central aortic BP and further report that the highest levels were among youth with SO. Our findings of higher central aortic BP among youth with OB coincidence with those of studies from other groups and extend these observations to a pediatric population with SO. [26] [27] [28] [29] [30] The relationship between OB, as measured by BMI, and peripheral BP has been well documented among both adult 31 and pediatric populations. [32] [33] [34] We observed that BMI was significantly associated with central aortic BP. Previous research in pediatrics has similarly reported brachial BP to be positively associated with various measures of adiposity, but most strongly with BMI. [35] [36] [37] Despite data implicating abdominal fat as a determinant in the development of high BP measured in the brachial artery among adults, 38 BMI appears to be more closely associated central aortic BP among children and adolescents. Perhaps the relatively short period of exposure to excess adiposity and/or the ability to physiologically compensate for increased adiposity may explain our findings.
The strong association with BMI may also be potentially a result from the effect of height on BP. Differences in central aortic BP between sexes were not observed in our study. Because the interaction from the multivariate analysis was not significant, we further conclude that the association between elevated central aortic BP and OB status does not differ between sexes in children or adolescents. Previous research in peripheral BP reported that sex differences emerge at the onset of adolescence, with males exhibiting higher SBP. 33, 39 Diaz et al. 40 measured central aortic BP among youth with an oscillometric device and reported that males exhibited higher central aortic BP. Discrepancies between studies could be attributed to differences in device methodology, and also a younger cohort in our study.
Strengths of this study include the relatively large sample size, inclusion of participants with a wide range of BMI values extending to the SO category, the use of dual-energy X-ray absorptiometry for measures of body composition, and the standardized methods used for measuring central aortic BP. Limitations include the cross-sectional nature of the study, which precludes us from suggesting causality between OB and increased central aortic BP. Participants were not screened for obstructive sleep apnea, which does not allow us to examine whether elevated central aortic BP occurs independently of obstructive sleep apnea in the context of severe pediatric OB. It is also important to note that neither categories nor percentiles exist for central aortic BP, which somewhat limits the ability to interpret the findings from a clinical perspective.
In conclusion, children and adolescents with SO have higher levels of central aortic BP compared with peers with OW/OB or NW. The importance of this study is that it provides evidence that OB-related impairments in central aortic BP and increased CVD risk appear to occur within the first 2 decades of life. Compared with percent fat mass or visceral adipose tissue, BMI was more strongly associated with central aortic BP among children and adolescents, suggesting body size may be a more important determining factor than adiposity during childhood.
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